| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | US20040018189 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 01/29/2004 | US20040018184 Administering mixtures of monocytes and drugs selected from taxanes, alkaloids, antibiotics or enzyme inhibitors, as anticarcinogenic agents |
| 01/29/2004 | US20040018180 Administering hematopoietic stem cells for activation of glands, to improve immune response to vaccines; leutinizing hormone-releasing hormone |
| 01/29/2004 | US20040018177 Vacination method |
| 01/29/2004 | US20040018152 Biologically active molecules encapsulated in self-assembling, diketopiperazine microspheres, TECHNOSPHEREs tm ) and methods for making and administering such compositions are described herein. The compositions can be used to immunize individuals |
| 01/29/2004 | DE10229872A1 Immunstimulation durch chemisch modifizierte RNA Immune stimulation by chemically modified RNA |
| 01/29/2004 | DE10229379A1 EG-VEGF Rezeptor Antagonisten EG-VEGF receptor antagonists |
| 01/29/2004 | CA2803741A1 Treatment of psoriasis with human anti-tnf alpha antibody |
| 01/29/2004 | CA2800126A1 Treatment of tnf.alpha. related disorders |
| 01/29/2004 | CA2493706A1 Igg fc/hiv-gp120/c3d fusion protein |
| 01/29/2004 | CA2493406A1 Gm-negative ehv-mutants without heterologous elements |
| 01/29/2004 | CA2493182A1 Compositions and methods for treating and preventing infection |
| 01/29/2004 | CA2493067A1 Treatment of tnf.alpha. related disorders |
| 01/29/2004 | CA2492878A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492377A1 Recombinant production of mixtures of antibodies |
| 01/29/2004 | CA2489008A1 Ghrelin-carrier conjugates |
| 01/29/2004 | CA2487849A1 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/28/2004 | EP1384487A1 Drugs containing genetically modified antibody against ganglioside gd3 |
| 01/28/2004 | EP1384403A1 Adjuvant for transcutaneous immunization |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383918A2 An animal model for enteric pathogens |
| 01/28/2004 | EP1383896A2 Haemophilus influenzae antigens |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383872A2 Genetically modified yt cell line and use thereof |
| 01/28/2004 | EP1383802A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 01/28/2004 | EP1383801A1 Antibodies against cancer |
| 01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
| 01/28/2004 | EP1383796A1 Neurovirulent strain of the west nile virus and applications thereof |
| 01/28/2004 | EP1383795A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383785A2 Recombinant tumor specific antibody and use thereof |
| 01/28/2004 | EP1383573A2 Methods and apparatus for treating diseased tissue |
| 01/28/2004 | EP1383571A2 Microprojection array immunization patch and method |
| 01/28/2004 | EP1383556A1 Injection device for administering rna |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383535A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 01/28/2004 | EP1383534A2 Chlamydia vaccine composition |
| 01/28/2004 | EP1383532A2 Combination therapy |
| 01/28/2004 | EP1383531A2 Use of lp82 to treat hematopoietic disorders |
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383526A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/28/2004 | EP1383514A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/28/2004 | EP1383513A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 01/28/2004 | EP1383490A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/28/2004 | EP1383386A1 Improved anti-inflammatory herbal composition and method of use |
| 01/28/2004 | EP1383379A1 Restoration of cancer-suppressing functions to neoplastic cells through dna hypomethylation |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0636030B1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471580A Virus Particles with exogenous internal eitopes |
| 01/28/2004 | CN1471579A CRIPTO tumour polypeptide |
| 01/28/2004 | CN1471575A Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 01/28/2004 | CN1471539A Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 01/28/2004 | CN1470637A Hepatitis B virus core protein mutant and its use |
| 01/28/2004 | CN1470530A Humanmachine tumour monoclonal antibody, and its preparing method and use |
| 01/28/2004 | CN1470287A Use of isatis root extract in immunological adjuvant |
| 01/28/2004 | CN1470286A Medicinal composition for immunopotentiation and its preparing method |
| 01/28/2004 | CN1470285A Polypeptide vaccine of anti Asiatic I virus of foot-and-mouth disease and its preparing method |
| 01/28/2004 | CN1136230C Urogenital carcinoma TLP complex peptides and antibodies thereof |
| 01/28/2004 | CN1136010C Method for making Subunit antigen vaccine cream |
| 01/28/2004 | CN1135970C Use of micro particles having a protein and an antiboby absorbed theron for preparing a pharmaceutical composition for intranasal administration |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683052 Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions |
| 01/27/2004 | US6683049 Relieving pain from neuromuscular disorders using botulinum toxins |
| 01/27/2004 | US6682928 Cell is transformed to express on its surface a component which binds to an fc receptor of an effector cell used as a vehicle to increase an cell lysis and phagocytosis against an antigen associated with the cell |
| 01/27/2004 | US6682919 Polynucleotide sequence encodes the same mature polypeptide, expressed by the fabh gene contained in staphylococcus aureus |
| 01/27/2004 | US6682909 Polypeptide for use in the diagnosis, treatment and prevention of hepatitis infections |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682746 Adjuvanted vaccine which is substantially free of non-host albumin |
| 01/27/2004 | US6682745 Submucosal delivery of live bacteria; reducing local reaction; lower attenuation |
| 01/27/2004 | US6682743 Genetically engineered virus for use in the propagation of preferential cells |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | US6682741 Vaccination and tumor therapy |
| 01/27/2004 | US6682737 Monoclonal antibody having the same or overlapping epitope binding specificity as that of 3e2 secreted by hybridoma atcc hb 12075 |
| 01/27/2004 | US6682735 Anti-IgE antibodies |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682731 Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules |
| 01/27/2004 | CA2105644C Resurfacing of rodent antibodies |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008147A2 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | WO2004007747A2 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | WO2004007734A1 Her-2/neu dna vaccine having anti-cancer activity |
| 01/22/2004 | WO2004007726A2 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007722A2 Transgenic animal expressing alzheimer’s tau protein |
| 01/22/2004 | WO2004007701A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | WO2004007697A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |